Company intelligence / Profile preview

SpeechVive

Lafayette, Indiana, United Statesspeechvive.com ↗

Ownership: Private
Development stage: Commercial

Overview

Clinical trials and real-world use have shown that the SpeechVive device provides immediate improvement in speaking volume for approximately 75–80% of people with Parkinson’s disease, with additional benefit seen after extended use. Multi-site peer-reviewed clinical trials demonstrated improvements in volume, articulation, and speech rate in up to 90% of participants. The product has been accepted by Medicare, Veterans Administration, and commercial insurance plans[1][2][4].

Therapeutic areas: Neurology
Modalities: DeviceNon-pharmacological therapyDigital health platform (telehealth)
Industry: Assistive Medical Devices

Partnerships

Purdue University (technology origin/research collaboration)[2][5]U.S. Department of Veterans Affairs/VA medical centers[4][5]

Beyond the preview

Go deeper on SpeechVive.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on SpeechVive.

Explore the full profile